Literature DB >> 25100076

Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade.

Naimeh Rafatian1, Katherine V Westcott1, Roselyn A White2, Frans H H Leenen3.   

Abstract

After myocardial infarction (post-MI), inflammation and apoptosis contribute to progressive cardiac remodeling and dysfunction. Cardiac mineralocorticoid receptor (MR) and β-adrenergic signaling promote apoptosis and inflammation. Post-MI, MR activation in the brain contributes to sympathetic hyperactivity and an increase in cardiac aldosterone. In the present study, we assessed the time course of macrophage infiltration and apoptosis in the heart as detected by both terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and active caspase-3 immunostaining in both myocytes and nonmyocytes, as well as the effects of central MR blockade by intracerebroventricular infusion of eplerenone at 5 μg/day on peak changes in macrophage infiltration and apoptosis post-MI. Macrophage numbers were markedly increased in the infarct and peri-infarct zones and to a minor extent in the noninfarct part of the left ventricle at 10 days post-MI and decreased over the 3-mo study period. Apoptosis of both myocytes and nonmyocytes was clearly apparent in the infarct and peri-infarct areas at 10 days post-MI. For TUNEL, the increases persisted at 4 and 12 wk, but the number of active caspase-3-positive cells markedly decreased. Central MR blockade significantly decreased CD80-positive proinflammatory M1 macrophages and increased CD163-positive anti-inflammatory M2 macrophages in the infarct. Central MR blockade also reduced apoptosis of myocytes by 40-50% in the peri-infarct and to a lesser extent of nonmyocytes in the peri-infarct and infarct zones. These findings indicate that MR activation in the brain enhances apoptosis both in myocytes and nonmyocytes in the peri-infarct and infarct area post-MI and contributes to the inflammatory response.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  aldosterone; brain; cardiac remodeling; cell death; inflammation; mineralocorticoid receptors

Mesh:

Substances:

Year:  2014        PMID: 25100076     DOI: 10.1152/ajpregu.00075.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  14 in total

1.  Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction.

Authors:  Zhonglin Liu; Christy Barber; Akash Gupta; Li Wan; Young-Wook Won; Lars R Furenlid; Qin Chen; Ankit A Desai; Ming Zhao; David A Bull; Evan C Unger; Diego R Martin
Journal:  Nucl Med Biol       Date:  2019-01-17       Impact factor: 2.408

2.  Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis.

Authors:  Grace J Lee; Lin Yan; Dorothy E Vatner; Stephen F Vatner
Journal:  Basic Res Cardiol       Date:  2015-01-20       Impact factor: 17.165

3.  Constructing and evaluating caspase-activatable adeno-associated virus vector for gene delivery to the injured heart.

Authors:  Mitchell J Brun; Kefan Song; Byunguk Kang; Cooper Lueck; Weitong Chen; Kaitlyn Thatcher; Erhe Gao; Walter J Koch; Joy Lincoln; Sudarsan Rajan; Junghae Suh
Journal:  J Control Release       Date:  2020-11-04       Impact factor: 9.776

4.  Effects of Sodium Restriction on Activation of the Renin-Angiotensin-Aldosterone System and Immune Indices During HIV Infection.

Authors:  Suman Srinivasa; Tricia H Burdo; Kenneth C Williams; Emilie K Mitten; Kimberly Wong; Kathleen V Fitch; Takara Stanley; Gail K Adler; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2016-08-22       Impact factor: 5.226

5.  Degradable acetalated dextran microparticles for tunable release of an engineered hepatocyte growth factor fragment.

Authors:  Sophia L Suarez; Adam Muñoz; Aaron Mitchell; Rebecca L Braden; Colin Luo; Jennifer R Cochran; Adah Almutairi; Karen L Christman
Journal:  ACS Biomater Sci Eng       Date:  2015-12-14

Review 6.  The renin-angiotensin-aldosterone system and its suppression.

Authors:  Marisa K Ames; Clarke E Atkins; Bertram Pitt
Journal:  J Vet Intern Med       Date:  2019-02-26       Impact factor: 3.333

7.  Inhibition of inflammation by minocycline improves heart failure and depression-like behaviour in rats after myocardial infarction.

Authors:  Hong-Wei Wang; Monir Ahmad; Rami Jadayel; Fatimah Najjar; Diane Lagace; Frans H H Leenen
Journal:  PLoS One       Date:  2019-06-24       Impact factor: 3.240

Review 8.  Regulation of Type 2 Immunity in Myocardial Infarction.

Authors:  Jun-Yan Xu; Yu-Yan Xiong; Xiao-Tong Lu; Yue-Jin Yang
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

9.  Spironolactone Effect in Hepatic Ischemia/Reperfusion Injury in Wistar Rats.

Authors:  Julio César Jiménez Pérez; Araní Casillas Ramírez; Liliana Torres González; Linda Elsa Muñoz Espinosa; Marlene Marisol Perales Quintana; Gabriela Alarcón Galván; Homero Zapata Chavira; Francisco Javier Guzmán de la Garza; Carlos Rodrigo Cámara Lemarroy; Nancy Esthela Fernández Garza; Edelmiro Pérez Rodríguez; Paula Cordero Pérez
Journal:  Oxid Med Cell Longev       Date:  2015-12-21       Impact factor: 6.543

Review 10.  Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction.

Authors:  Yonggang Ma; Alan J Mouton; Merry L Lindsey
Journal:  Transl Res       Date:  2017-10-13       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.